Skip to main content

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Ministry of Trade and Industry
  1. Home
  2. Newsroom
  3. Oral reply to PQ on Percentage of Jointly-created Intellectual Properties Generating Little or No Licensing Revenue for Singapore
3. Parliamentary replies

Oral reply to PQ on Percentage of Jointly-created Intellectual Properties Generating Little or No Licensing Revenue for Singapore

25 September 2025

This article has been migrated from an earlier version of the site and may display formatting inconsistencies.

Question

Mr Kenneth Tiong Boon Kiat: To ask the Deputy Prime Minister and Minister for Trade and Industry in respect of joint public-private R&D Corporate Laboratories (CLs) funded under the Research, Innovation and Enterprise (RIE) plans (a) what percentage of jointly-created Intellectual Properties generate (i) zero or (ii) only nominal licensing revenue for the Singapore public entity; and (b) how is the Government ensuring taxpayers secure commensurate returns for such CLs.

Oral Answer (to be attributed to Deputy Prime Minister and Minister for Trade and Industry Gan Kim Yong) 

  1. Under RIE, the Industry Alignment Fund-Industry Collaboration Projects scheme (IAF-ICP) was established to encourage public sector researchers to pursue R&D in partnership with industry. One of the modalities for such collaborations is through public-private Corporate Laboratories (CL) where public sector researchers work alongside the partner companies’ researchers. In RIE 2025, about 80% of the Corporate Laboratory projects supported under IAF-ICP have licensing revenue expected from jointly-created Intellectual Properties (IP).

  2. Beyond licensing revenue, such projects seek to foster economic growth through helping the partner companies develop new products, and also to train a skilled, industry-ready research workforce. Furthermore, these collaborations build up the track record and credibility of our public research organizations amongst industry players, thereby enhancing the attractiveness of Singapore for corporates to anchor their research and innovation hubs.

  3. For example, the S$110 million Wilmar-NUS Corporate Laboratory strengthened Singapore as a leading centre for Asian-centric studies in translational medicine, nutritional sciences, healthy ageing and synthetic biology. It has trained over 70 researchers and PhD students, and also developed IP that has the potential to unlock new markets, with potential licensing revenue of US$25 million.

  4. Another example is A*STAR’s Institute of Microelectronics’ (IME) partnership with Applied Materials to establish the Centre of Excellence in Advanced Packaging. Since its inception, in 2011, the Centre has created more than 120 innovation jobs and benefitted at least 60 industry partners in product development. More recently, in 2024, Applied Materials chose Singapore to host its global Equipment and Process Innovation and Commercialisation (EPIC) platform for advanced chip packaging technologies. This enables our workforce and local companies such as ACE United Technologies and PBA Group to be at the forefront of technological innovation.

Back to top